-
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
Tasci, Elif Senocak; Oyan, Basak; Soenmez, Oezlem; Mutlu, Arda Ulas; Atci, Muhammed Mustafa; Sakin, Abdullah; Oener, Irem (Bmc, 2024)Background The optimal treatment for metastatic colorectal cancer (mCRC) after the second line is still controversial. Regorafenib has been the standard of care in this setting as it improved overall survival (OS) compared ... -
Development of Acute Pulmonary Hypertension After Bortezomib Treatment in a Patient With Multiple Myeloma: A Case Report and the Review of the Literature
Akosman, Cengiz; Ordu, Cetin; Eroglu, Elif; Oyan, Basak (LIPPINCOTT WILLIAMS & WILKINS, 2015)Bortezomib is widely used in treatment of multiple myeloma. In recent years, severe bortezomib-induced lung injury has been reported. The clinical course is generally characterized with fever and dyspnea, followed by ...
